GLP-1 S (20mg) $259.00 GLP-1 S (20mg) is a synthetic glucagon-like peptide-1 (GLP-1) analog developed for use in preclinical and clinical research
Energy 350 , 123937 (2024)
states where cannabis is now legal
It is released within minutes of eating and does several important things simultaneously: Signals the hypothalamus to reduce hunger and increase satiety Stimulates insulin secretion from the pancreas (glucose-dependent so it does not cause hypoglycaemia on its own) Suppresses glucagon, which prevents excess glucose from being released by the liver Slows gastric emptying, so you stay full longer after meals May have cardioprotective and neuroprotective effects In people with insulin resistance, fatty liver, or type 2 diabetes, GLP-1 secretion is often impaired or the body's response to it is blunted
These signaling cascades enhance glucose-dependent insulin secretion, inhibit glucagon release, slow gastric emptying, and promote pancreatic -cell survival and proliferation
Wegovy injection site reactions Some people may experience skin irritation at the injection site, including rash, itchiness, or redness